Cellular Dynamics International

Cellular Dynamics International develops stem cell technologies for drug development and personalized medicine applications.

Cellular Dynamics International, Inc. develops stem cell technologies for drug development and personalized medicine applications. It offers drug screening and toxicity testing products based on induced pluripotent stem (iPS) cell technology. The company also provides cardiac toxicity drug testing services, including GLP and non-GLP hERG electrophysiological assays, as well as action potential and cytotoxicity screens using cardiomycytes. In addition, it offers pluripotent stem cell derived products, including cardiomyocytes, hematopoietic cells, neural cells, and hepatocytes. Cellular Dynamics International, Inc. was formerly known as iPS Cells Inc. and changed its name to Cellular Dynamics International, Inc. in July 2008. The company was founded in 2004 and is based in Madison, Wisconsin.